212
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Fexofenadine/Cyclodextrin Inclusion Complexation: Phase Solubility, Thermodynamic, Physicochemical, and Computational Analysis

, , &
Pages 1205-1215 | Published online: 25 Sep 2008
 

Abstract

Interactions of fexofenadine (Fexo) with cyclodextrins (CDs: α- β-, γ-, and HP-β-CD) were investigated by several techniques including phase solubility, differential scanning calorimetry (DSC), X-ray powder diffractometry (XRPD), 1H-nuclear magnetic resonance (1H-NMR) and molecular mechanical modeling (MM+). The effects of CD type, pH, ionic strength, and temperature on complex stability were also explored. Fexo/CD complex formation follows the decreasing order: β-CD > HP-β-CD > γ-CD > α-CD (i.e., at pH 7.0 and 30°C, K11 = 1139, 406, 130, and 104 M−1, respectively). The linear correlation of the free energy of Fexo/β-CD complex formation (ΔG11) with the free energy of inherent Fexo solubility (ΔGSo), obtained from the variation of K11 with inherent Fexo solubility (So) at different pHs and ionic strengths, was used to measure the contribution of the hydrophobic character of Fexo to escape from water by including into the hydrophobic CD cavity. The hydrophobic effect (desolvation) contributes about 76% of the total driving force towards inclusion complex formation, while specific interactions contribute −7.7 kJ/mol. Moreover, Zwitterionic Fexo/β-CD complex formation appears to be driven both by favorable enthalpy (ΔH° = −23.2 kJ/mol) and entropy (ΔS° = 15.2 J/mol.K) changes at pH 7.0. 1H-NMR and MM+ studies indicate multimodal inclusion of the piperidine, carboxypropylphenyl, and phenyl moieties into the β-CD cavity. MM+ computations indicate that the dominant driving force for complexation is Van der Waals force with very little electrostatic contribution. 1H-NMR, DSC, and XRPD studies indicate the formation of inclusion complex in aqueous solution and the solid state.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.